LD-2 disclosure · 4th Quarter - Report
GVB BIOPHARMA
Client
- Name
- GVB BIOPHARMA
- Description
- CBD extraction and distillation
- Location
- Nevada · United States of America
Registrant
- Description
- Government relations and business consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesAgriculture
Discussions relating to regulation of the CBD industry. Discussions relating to Farm Bill Reauthorization. Discussions relating to regulation of Delta-8 THC. Monitored H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 (All sections of full text) Monitored S. 253 Cannabidiol and Marihuana Research Expansion Act. Monitored S. 910 Secure and Fair Enforcement (SAFE) Banking Act. Monitored executive branch nominations to federal agencies and commissions.
LobbyistsTREVOR W. KOLEGO · MICHAEL A. GAFFIN · mr JOHN CHRISTIE iii
TargetedHOUSE OF REPRESENTATIVES
Law Enforcement/Crime/Criminal Justice
Monitored H.R. 6129, HOPE Act of 2021 Monitored H.R. 3617, MORE Act of 2021
LobbyistsTREVOR W. KOLEGO